Recent Advances in Treatment of Retinitis Pigmentosa

Author(s): Yuxi He , Yan Zhang , Guanfang Su .

Journal Name: Current Stem Cell Research & Therapy

Volume 10 , Issue 3 , 2015

Become EABM
Become Reviewer


Retinitis pigmentosa (RP) is a group of inherited retinal disorders characterized by the progressive photoreceptors and pigment epithelial cells dysfunction. It is the most common retinal degeneration, responsible for loss of vision of most people worldwide. Until now its exact pathogenesis and etiology are not clear. So far there is no approved therapy. New approaches for RP therapy include cell transplantation, gene therapy, cytokine therapy, nutrition therapy, and hyperbaric oxygen therapy. Such therapies for retinal degenerative diseases are limited in their efficacy. This paper reviews the relevant documents, especially recent researches, and reviews advances in the treatment of RP.

Keywords: Cell transplantation, cytokine therapy, gene therapy, hyperbaric oxygen therapy, nutrition therapy, retinitis pigmentosa.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Page: [258 - 265]
Pages: 8
DOI: 10.2174/1574888X09666141027103552
Price: $58

Article Metrics

PDF: 96